NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for FAP 1


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Alnylam Provides Update on RNAi Pipeline, Platform, and Technology at Its R&D Day
2009 NOV 23 ... familial amyloidotic cardiomyopathy (FAC) and familial amyloidotic polyneuropathy (FAP). ATTR is caused by mutations in the TTR gene, which is expressed in the liver, that ...
Subject: Alnylam Pharmaceuticals, Inc.
Price: $3.00
*
Cequent Files its First IND with FDA: CEQ508, a tkRNAi Drug Candidate in Oncology
2009 NOV 23 ... polyps to colorectal cancer. Cequent expects to begin the Phase I clinical trial in the FAP (familial adenomatous polyposis) patient population during the first quarter of 2010 at ...
Subject: Cancer
Price: $3.00
*
Cequent to Provide Details at BIOCOM About Planned Launch of its Clinical Program - 3 p.m., Tuesday, October 27
2009 NOV 1 ... Administration for an orally administered tkRNAi drug targeting the primary oncogene in FAP (familial adenomatous polyposis) before the end of the quarter. FAP is a rare inherited ...
Subject: RNA Research
Price: $3.00
*
New adenomatous polyp data have been reported by researchers at University of Amsterdam
2009 OCT 5 ... polyposis occurs in approximately 90% of patients with familial adenomatous polyposis (FAP) and 5%-10% develop duodenal cancer. Novel imaging techniques may improve evaluation of ...
Subject: Adenomatous Polyp
Price: $3.00
*
New adenomatous polyp genetics data have been reported by B. Filipe and co-authors
2009 OCT 19 ... MUTYH mutations account for the majority of clinically well-characterized families with FAP and AFAP phenotype and patients with more than 30 adenomas,' is the subject of a ...
Subject: Adenomatous Polyp Genetics
Price: $3.00
*
New adenomatous polyp study findings reported from University Hospital
2009 SEP 7 ... "Familial adenomatous polyposis (FAP) is an autosomal dominant form of intestinal polyposis and colorectal cancer caused by ...
Subject: Adenomatous Polyp
Price: $3.00
*
New data from A.P. Barreiros et al illuminate research in amyloidosis
2009 OCT 12 ... forms of amyloidosis (19 patients with TTR-amyloidosis (familial amyloid Polyneuropathy [FAP]), 11 patients with other forms of systemic amyloidosis) were sonographically evaluated ...
Subject: Amyloidosis
Price: $3.00
*
Reports on adenomatous polyp findings from University of Virginia provide new insights
2009 NOV 9 ... involvement, specimen integrity and mat-gin status. Familial adenomatous polyposis (FAP) status and the endoscopist's impression of completeness of removal were also ...
Subject: Adenomatous Polyp
Price: $3.00
*
Reports summarize adenoma study results from Prince of Wales Hospital
2009 NOV 17 ... in detail the psychosocial impact of either having familial adenomatous polyposis (FAP) or being at risk for FAP amongst young adults. In-depth interviews were conducted with ...
Subject: Adenoma
Price: $3.00
*
Reports summarize adenomatous polyposis coli study results from University of Oslo
2009 OCT 19 ... "Familial adenomatous polyposis (FAP) is an autosomal dominantly inherited disease caused by mutations in the adenomatous ...
Subject: Adenomatous Polyposis Coli
Price: $3.00
*
Research from University of Lisbon, Medical Department has provided new information about liver transplant
2009 SEP 21 ... following liver transplantation between patients with Familial Amyloid Polineuropathy (FAP) and patients with liver disease. Patient's mental quality of life showed an ...
Subject: Liver Transplant
Price: $3.00
*
Research from University of Minnesota broadens understanding of molecular biology
2009 SEP 8 ... but lacks at least four subunits: IC138, IC97, LC7b, and flagellar-associated protein (FAP) 120-defining a new I1 subcomplex." "Electron microscopy and image ...
Subject: Molecular Biology
Price: $3.00
*
Researchers from Erasmus University report on findings in adenomatous polyp
2009 NOV 1 ... polyposis coli (APC) gene are responsible for familial adenomatous polyposis (FAP), an autosomal dominant hereditary predisposition to the development of multiple ...
Subject: Adenomatous Polyp
Price: $3.00
*
Researchers from Tohoku University, Department of Orthopaedic Surgery discuss findings in bone research
2009 NOV 2 ... and soft tissue tumours,' is the subject of a report. "Fibroblast activation protein (FAP)/seprase and dipeptidylpeptidase-IV (DPP-IV)/CD26 are serine integral membrane ...
Subject: Bone Research
Price: $3.00
*
Researchers from University Hospital, Department of Surgery describe findings in proctocolectomy
2009 NOV 2 ... in the management of ulcerative colitis (UC) and familial adenomatous polyposis (FAP). We review outcome of pouch surgery from a single centre, comparing non-South Asian and ...
Subject: Proctocolectomy
Price: $3.00
*
Researchers from University of Bari report details of new studies and findings in the area of colon cancer
2009 SEP 28 ... in colorectal tumours of Apc(Min/+) and patients with familial adenomatous polyposis (FAP). The human IRS2 promoter region presents several CDX2-binding sites where CDX2 ...
Subject: Colon Cancer
Price: $3.00
*
Scientists at China University discuss research in enzyme research
2009 NOV 23 ... "The optimum water activity is 0.19 and Newlase F (Rhizopus niveus), lipase FAP-15 (Rhizopus oryzae) belong to this type. The second type is lipase that has medium ...
Subject: Enzyme Research
Price: $3.00
*
Studies from University of Stuttgart reveal new findings on necrosis
2009 SEP 8 ... Using a scFv directed against the tumor stroma marker fibroblast activation protein (FAP) we show that TLP and scTNF-TLP specifically bind to FAP-expressing, but not to ...
Subject: Necrosis
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login